✦ LIBER ✦

379 Antifibrotic activity of refanlin, a hepatocyte growth factor analogue in vitro and in experimental liver fibrosis

✍ Scribed by Carlos Alvarez; Peter Mento; Prakash Narayan; Itzhak D. Goldberg; Scott Friedman; Efsevia Albanis

Book ID: 119530287
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 122 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1016/s0270-9139(03)80422-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antifibrogenic effect of a deletion vari

Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats

✍ H Yasuda; E Imai; A Shiota; N Fujise; T Morinaga; K Higashio 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 847 KB

which may be modulated by the most potent fibrogenic cyto-Hepatic fibrosis, which may lead to cirrhosis, is associkine, transforming growth factor b 1 (TGF-b 1 ). 5,6 Hepatic fiated with most chronic liver diseases. Current therapies brosis is associated with an activation of lipocytes. 2 In hepatic

Antifibrogenic effect of a deletion vari

Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats

✍ H Yasuda; E Imai; A Shiota; N Fujise; T Morinaga; K Higashio 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 836 KB

Hepatocyte growth factor overexpression

Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis

✍ Hiroki Tojima, Satoru Kakizaki, Takashi Kosone, Norio Horiguchi, Yuichi Yamazaki 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 777 KB

138 POTENT ANTIFIBROTIC ACTIVITY OF MTOR

138 POTENT ANTIFIBROTIC ACTIVITY OF MTOR INHIBITORS SIROLIMUS AND EVEROLIMUS BUT NOT OF CYCLOSPORINE A AND TACROLIMUS IN EXPERIMENTAL LIVER FIBROSIS

✍ E. Patsenker; M. Ledermann; H. Saegesser; V. Schneider; F. Stickel 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

In vivo and in vitro effects of transfor

In vivo and in vitro effects of transforming growth factor-β1-activation-related peptide on hepatocyte transformation and hepatic fibrosis

✍ Hiroki Kondou; Sotaro Mushiake; Yoko Miyoshi; Hitoshi Tajiri; Shintaro Okada 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Inhibition of neoplastic development in

Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model Laboratory of Experimental Carcinogenesis, NCI NIH, Bethesda, MD, and * Massachusetts General Hospital Cancer Center, Cahrlestown, MA

📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB